![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Hologic Earns CE Mark Extension for RFID Tag
Hologic Earns CE Mark Extension for RFID Tag
![Hologic logo](https://www.fdanews.com/ext/resources/test/Device_Images6/Hologic_Logo.gif?t=1624653890&width=430)
Hologic has earned extended CE Mark approval for its LOCalizer radiofrequency identification (RFID) tag for long-term placement in breast lesions.
The non-radioactive guidance system’s expanded CE Mark means that the tag can now be placed in patients more than 30 days before breast-conserving surgery.
The device is used to accurately mark and target breast lesions during surgery and eliminates the need to place a wire before beginning the procedure.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct